Filing Details
- Accession Number:
- 0001628280-25-024346
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-09 17:02:33
- Reporting Period:
- 2025-04-01
- Filing Date:
- 2025-05-09
- Accepted Time:
- 2025-05-09 17:02:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 1600 West End Ave., Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-04-01 | 45 | $4.24 | 283,763 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-02 | 45 | $4.39 | 283,808 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-03 | 45 | $4.21 | 283,853 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-04 | 45 | $4.23 | 283,898 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-07 | 45 | $4.19 | 283,943 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-08 | 45 | $4.14 | 283,988 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-09 | 45 | $4.09 | 284,033 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-10 | 45 | $4.01 | 284,078 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-11 | 45 | $4.02 | 284,123 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-14 | 55 | $4.03 | 284,178 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-15 | 55 | $4.14 | 284,233 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-16 | 55 | $4.23 | 284,288 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-17 | 55 | $4.61 | 284,343 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-21 | 55 | $4.79 | 284,398 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-22 | 55 | $4.74 | 284,453 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-23 | 55 | $5.01 | 284,508 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-24 | 55 | $5.12 | 284,563 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-25 | 55 | $4.94 | 284,618 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-28 | 45 | $4.91 | 284,663 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-29 | 45 | $4.93 | 284,708 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-04-30 | 45 | $4.79 | 284,753 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.
Billionaire Hedge Funds
